These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19885248)

  • 1. The implantable peritoneal pump--a patient's perspective.
    Witkowski CJ; Saudek C
    J Diabetes Sci Technol; 2008 Jul; 2(4):703-6. PubMed ID: 19885248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable insulin pump therapy: an unusual presentation of a catheter-related complication.
    Moore KB; Saudek CD; Greene A; Dackiw A
    Diabetes Technol Ther; 2006 Jun; 8(3):397-401. PubMed ID: 16800761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Christopher Dyer Saudek, MD: diabetes expert and implantable insulin pump pioneer.
    Golden SH; Kalyani RR; Donner T
    Diabetes Care; 2013 Mar; 36(3):495-7. PubMed ID: 23431091
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraperitoneal delivery of insulin via mechanical pump: surgical implications.
    Udelsman R; Boyne MS; Loman KE; Saudek CD
    Langenbecks Arch Surg; 2000 Oct; 385(6):367-72. PubMed ID: 11127519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration of pump for intrathecal drug delivery into the peritoneal cavity. Case report.
    Vanhauwaert DJ; Kalala JP; Baert E; Hallaert G; Crombez E; Caemaert J; Van Roost D
    Surg Neurol; 2009 May; 71(5):610-2; discussion 612. PubMed ID: 18291481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience in human diabetics with portable and implantable insulin minipumps.
    Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Hedon B; Mares P; Franetzki M; Prestele K; Millet P; Beraud JJ
    Life Support Syst; 1983; 1(1):39-49. PubMed ID: 6678370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital at Home for Intrathecal Pump Refills: A Prospective Effectiveness, Safety and Feasibility Study.
    Goudman L; De Smedt A; Huygens R; Noppen M; Vanschoenwinkel M; Hatem SM; Moens M
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding the right route for insulin delivery - an overview of implantable pump therapy.
    Bally L; Thabit H; Hovorka R
    Expert Opin Drug Deliv; 2017 Sep; 14(9):1103-1111. PubMed ID: 27911116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Pump Malfunction During Hospitalization: Two Case Reports.
    Faulds ER; Wyne KL; Buschur EO; McDaniel J; Dungan K
    Diabetes Technol Ther; 2016 Jun; 18(6):399-403. PubMed ID: 27027151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events.
    Cope JU; Morrison AE; Samuels-Reid J
    Pediatrics; 2008 May; 121(5):e1133-8. PubMed ID: 18450857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin pump therapy in type 1 diabetes mellitus.
    Liberatore Rdel R; Damiani D
    J Pediatr (Rio J); 2006; 82(4):249-54. PubMed ID: 16912828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences with diabetes mellitus and implantable insulin pump therapy: a summary of interview data.
    Meize-Grochowski AR
    Diabetes Educ; 1989; 15(1):50-5. PubMed ID: 2910689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus.
    Lau YN; Korula S; Chan AK; Heels K; Krass I; Ambler G
    Pediatr Diabetes; 2016 Aug; 17(5):319-26. PubMed ID: 25998469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an implantable pump for controlled subcutaneous insulin delivery in healthy cats.
    Zini E; Padrutt I; Macha K; Riederer A; Pesaresi M; Lutz TA; Reusch CE
    Vet J; 2017 Jan; 219():60-64. PubMed ID: 28093115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.